Not all erythematosquamous eruptions are psoriasis.
When confronted with an acute erythematosquamous outbreak, a mere diagnosis of guttate psoriasis will not suffice.
- Some thought must be given to secondary syphilis and primary HIV infection and to making a serological assessment
- Pityriasis rosea may pose a problem, with its oval erythematosquamous maculae and peripheral collarette scaling, often arranged on the back in the form of a “Christmas tree”. One must look for the largest-sized initial patch predating the generalized outbreak by several days. Spontaneous clearing within a few weeks will provide final reassurance.
- Eruptive forms of guttate parapsoriasis - with their “sealing wax” scales detaching from a block with a curette, and the juxtaposition of differently aged papular, squamous then pigmented, cicatricial components - may raise questions, especially since they tend to develop towards chronicity. Diagnostic can be confirmed by means of anatomico-pathological examination.
- Lichen planus, with its violaceous papules covered in fine whitish latticework, its cutaneous and mucous attack and the extent of the pruritus, will rarely pose problems except in the palmoplantar and/or ungual sites, where a biopsy will be sometimes necessary.
Faced with a chronic erythematosquamous outbreak, diagnosis may be more difficult:
- Nummular eczema is sometimes difficult to tell apart from inflammatory and pruritic psoriasis. Biopsy will not always be of much help, and it is mainly the questioning with the help of the allergological testing that will enable a diagnosis to be made. One should not forget that contact eczema might be at the root of Köebner’s phenomenon, and thereby associated with psoriasis.
- Porokeratosis will not pose a diagnostic problem as long as lesions are carefully examined, allowing to detect the highly characteristic “surrounding wall” edging. Only palmoplantar sites may pose problems.
- The distinction between psoriasis and pityriasis rubra pilaris is much more difficult. The follicular hyperkeratosis, the yellow colour of the palmoplantar keratoderma and the hyperkeratosis of the hand lines, the chalky appearance of the face and the spaces left for healthy skin, so characteristic of pityriasis rubra pilaris, are not always present. The histological signs are essentially negative, since there is no visible migration of neutrophilic polynuclears in pityriasis rubra pilaris, but they are not always observed in psoriasis. Finally, some psoriasis, particularly in children, start in the form of what we French call “spinulosism” with peripilar hyperkeratosis, especially on the tibial crests. There will be cases in which the diagnosis can only be rectified in step with the evolution.
- Parapsoriasis en plaque, early forms of mycosis fungoides, may look very much like psoriasis. Moreover, certain psoriasis have proved capable of evolving towards a cutaneous T cell lymphoma. That is why T cell lymphoma should always be suspected when faced with pruritic psoriasis, and it could be necessary to perform and repeat biopsies.
- Finally, faced with erythematosquamous pruritic lesions, the existence of Norwegian scabies should be borne in mind.
Some clinical forms of psoriasis pose special problems as regards differential diagnosis.
- Erythrodermae cannot be distinguished one from another with any certainty by clinical examination alone. Therefore, when considering any erythroderma, not only will any past history of psoriasis need to be sought but also anything that may be reminiscent of drug-induced toxidermia, generalized contact or atopic eczema, pityriasis rubra pilaris or cutaneous T cell lymphoma of the Sézary syndrome type. Erythroderma is always a medical emergency.
- Conversely, some highly localized erythematosquamous lesions must not be judged to be psoriasis too hastily. Thought must be given to the possibility of Bowen or Paget disease and to performing a biopsy. The difficulty in diagnosing is particularly important when psoriasis is combined with actinic keratosis or pagetoid basal cells carcinoma. This is not a rare situation, given that numerous antipsoriatic treatments are prone to favouring the occurrence of skin carcinomas. In this situation, the only way of not confusing clinically the two types of lesion is to eliminate the psoriatic lesions by a powerful treatment such as methotrexate, during the period necessary to treat the precancerous or cancerous lesions.
- Exanthametous pustulosis is generally easy to distinguish from pustular psoriasis, particularly by its onset around the skin folds and, of course, by its triggering by a drug; however, it is interesting to note that this toxidermia seems to present itself more often in psoriatics.
Some psoriasis sites pose specific differential diagnosis problems.
- Psoriasis in the folds is made of erythematous plaques, due to maceration and given to being pruritic. Particularly if isolated, these lesions are far too often considered, without mycological sampling, to be mycotic intertrigo. By contrast, the existence of intertrigo during classic psoriasis may have mycotic origins. Therefore, mycological sampling must not be forgotten.
- The same wrong diagnoses are often made in onychopathy. A distortion of the nail, particularly a toenail, may certainly be psoriatic but may be equally as well connected with a trichophyton’s infection or repeated traumas. Such traumas may trigger Köebner’s phenomenon in the nail. Here again, mycological sampling is of great help. [|I have very little to add to a well-written chapter. One area that has always given me personally a great deal of difficulty is distinguishing between psoriatic nails and onychomycosis, particularly in affected toenails. Thus, I do believe psoriatic nails are more prone to fungal infections. Could the opposite also be appropriate? Thus, in a psoriatic patient with positive mycology, does the treatment of the nail fungus potentially improve the underlying nail psoriasis? Better methodologies, outside of biopsying and mycological evaluations would be helpful to reduce the clinical problems inherent in psoriatic toenails.|auteur215]
- A diagnosis of palmoplantar keratoderma of psoriatic origin must always be discussed at length, especially if this palmoplantar keratoderma is isolated.
- Trichophytosis must always be searched for, especially since there is a secondary infection to a trichophyton in about 20% of psoriatic palmoplantar keratodermae and this secondary infection may produce Köebner’s phenomenon.
- Contact eczema or orthoergic dermatitis may look like psoriasis or be the trigger for palmoplantar psoriasis.
- Some T cell lymphomas may start with palmoplantar keratoderma.
- Climacteric palmoplantar keratoderma, occurring in postmenopausal women, often obese, is never associated by definition with psoriasis in other areas of the body. Most likely, it is a special ailment different from psoriasis
- .Palmoplantar keratodermae of genetic origin generally pose few diagnostic problems.
Many other skin diseases may be confused with psoriasis:
- 2019/10/29 Focus on...World Psoriasis Day 2019
- 2019/08/12 Focus on...Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...News from our SPIN Columbian members
- 2019/05/21 Focus on...SPIN2019 is now available on your screen!
- 2019/04/18 Focus on...SPIN Congress 2019 in Paris coming soon
News from the web office
- 2017/06/05PIN becomes SPIN - Skin Inflammation & Psoriasis International Network
- 2016/10/29PSO 2016 Congress - Webcasts Available!
- 2016/05/26PIN Survey on Phototherapy
- 2016/02/20PIN Study on Therapeutic Patient Education
- 2016/02/19World Directory of Psoriasis Medical Resources - February 2016 Update
- 2019/04/18 Focus on...SPIN Congress 2019 in Paris coming soon
- 2018/07/16SPIN Symposium at the Spring continental meeting - Tehran, 25-27 April 2018
- 2018/02/222nd National Meeting of the Egyptian Society for Psoriasis
- 2018/02/211st Psoriasis Symposium - Sarajevo 2017
- 2017/06/2815th São Paulo Meeting of Psoriasis and Vitiligo
News from medical groups
- 2018/04/183rd Turkish National Psoriasis Symposium
- 2017/06/21Brazilian Center for Psoriasis Studies joins SPIN!
- 2017/06/21Costa Rica Psoriasis Group - Meet them!
- 2017/02/02Works of the 1st Senegalese Psoriasis Day published!
- 2016/07/29Swiss S1 Guidelines for Systemic treatment of psoriasis vulgaris
News from patients associations
- 2017/02/08France Psoriasis - 2016 World Psoriasis Day
- 2016/05/26Senegal Patients Association joins PIN!
- 2015/08/04Epidermia Greece: a new partner association of PIN
- 2015/08/01Canadian Association of Psoriasis Patients joins PIN!
- 2015/04/09AEPSO Argentina launches digital map to find people with psoriasis in the country
Recent publications on Psoriasis and Atopic Dermatitis
Our ambition in a changing landscape of psoriasis treatments.
J Dermatolog Treat. 2020 Mar , 31, (2):105-107.
CARD14/CARMA2sh and TANK differentially regulate poly(I:C)-induced inflammatory reaction in keratinocytes.
J. Cell. Physiol.. 2020 Mar , 235, (3):1895-1902.
CARD14/CARMA2sh (CARMA2sh) is a scaffold protein whose mutations are associated with the onset of human genetic psoriasis and other inflammatory skin disorders. Here we show that the immunomodulatory adapter protein TRAF family member-associated NF-κB activator (TANK) forms a complex with CARMA2sh and MALT1 in a human keratinocytic cell line. We also show that CARMA2 and TANK are individually required to activate the nuclear factor κB (NF-κB) response following exposure to (...)see on pubmed
Prohibitin 1 interacts with signal transducer and activator of transcription 3 in T-helper 17 cells.
Immunol. Lett.. 2020 Mar , 219:8-14.
T-helper 17 (Th17) cells are involved in the occurrence and development of several inflammation-associated diseases. Interleukin (IL)-17, the main cytokine secreted by differentiated Th17 cells, mediates immunoreactions and plays important roles in immunological diseases, including psoriasis, rheumatic arthritis, and inflammatory bowel disease. The maturation and stabilization of the differentiated Th17 cell phenotype are associated with the expression of IL-17A, which is induced by the (...)see on pubmed
Off-label studies on apremilast in dermatology: a review.
J Dermatolog Treat. 2020 Mar , 31, (2):131-140.
Apremilast is a phosphodiesterase-4 inhibitor FDA approved for psoriatic arthritis and moderate to severe plaque psoriasis. In recent years, multiple studies have suggested other potential uses for apremilast in dermatology. A summary of these various studies will be a valuable aid to dermatologists considering apremilast for an alternative indication. The PubMed/MEDLINE and ClinicalTrials.gov databases were queried with the term 'apremilast,' with results manually screened to identify (...)see on pubmed
Atopic dermatitis induces anxiety- and depressive-like behaviors with concomitant neuronal adaptations in brain reward circuits in mice.
Prog. Neuropsychopharmacol. Biol. Psychiatry. 2020 Mar 02, 98:109818.
Clinically, it has been reported that atopic dermatitis (AD) has been linked with negative emotional problems such as depression and anxiety, thereby reducing the quality of life, but little is known about the molecular mechanism that underlies AD-associated emotional impairments. We sought to determine whether AD could induce anxiety- and depressive-like symptoms in mice and to identify pertinent signaling changes in brain reward circuitry. AD-like lesions were induced by the repeated (...)see on pubmed
Efficacy and safety of indigo naturalis ointment in Treating Atopic Dermatitis: A randomized clinical trial.
J Ethnopharmacol. 2020 Mar 25, 250:112477.
Indigo naturalis, a herbal medicine with a history of use dating back to ancient times, may be a good alternative topical treatment for atopic dermatitis (AD).see on pubmed